Literature DB >> 31776722

MRI patterns of muscle involvement in type 2 and 3 spinal muscular atrophy patients.

Claudia Brogna1, Lara Cristiano1,2, Tommaso Verdolotti3, Anna Pichiecchio4,5, Claudia Cinnante6, Valeria Sansone7, Luca Maria Sconfienza8,9, Angela Berardinelli10, Matteo Garibaldi11, Giovanni Antonini11, Marika Pane12, Maria Carmela Pera1, Laura Antonaci1, Luana Ficociello3, Emilio Albamonte7, Giorgio Tasca13, Chiara Begliuomini14, Tommaso Tartaglione2,15, Lorenzo Maggi16, Alessandra Govoni17, Giacomo Comi17, Cesare Colosimo3,15, Eugenio Mercuri18,19.   

Abstract

Only few studies have reported muscle involvement in spinal muscular atrophy using muscle MRI but this has not been systematically investigated in a large cohort of both pediatric and adult patients with type 2 and type 3 spinal muscular atrophy. The aim of the present study was to define possible patterns of muscle involvement on MRI, assessing both fatty replacement and muscle atrophy, in a cohort of type 2 and type 3 spinal muscular atrophy children and adults (age range 2-45 years), including both ambulant and non-ambulant patients. Muscle MRI protocol consisted in T1-weighted sequences acquired on axial plane covering the pelvis, the thigh, and the leg with contiguous slices. Each muscle was examined through its whole extension using a grading system that allows a semiquantitative evaluation of fatty infiltration. Thigh muscles were also grouped in anterior, posterior, and medial compartment for classification of global atrophy. The results showed a large variability in both type 2 and type 3 spinal muscular atrophy, with a various degree of proximal to distal gradient. Some muscles, such us the adductor longus and gracilis were always selectively spared. In all patients, the involvement was a combination of muscle atrophy and muscle infiltration. The variability observed may help to better understand both natural history and response to new treatments.

Entities:  

Keywords:  Fatty infiltration; Magnetic Resonance Imaging; Muscle atrophy; Spinal muscular atrophy

Year:  2019        PMID: 31776722     DOI: 10.1007/s00415-019-09646-w

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  14 in total

Review 1.  Spinal muscular atrophy: state of the art and new therapeutic strategies.

Authors:  Sonia Messina; Maria Sframeli; Lorenzo Maggi; Adele D'Amico; Claudio Bruno; Giacomo Comi; Eugenio Mercuri
Journal:  Neurol Sci       Date:  2021-04-19       Impact factor: 3.307

2.  MRI correlates of motoneuron loss in SMA.

Authors:  Alina Sprenger-Svačina; Johannes Haensch; Kilian Weiss; Nils Große Hokamp; David Maintz; Marc Schlamann; Gereon R Fink; Natalie Schloss; Kai Laukamp; Gilbert Wunderlich; Helmar C Lehmann; Thorsten Lichtenstein
Journal:  J Neurol       Date:  2022-10-01       Impact factor: 6.682

3.  Diminished muscle oxygen uptake and fatigue in spinal muscular atrophy.

Authors:  Jacqueline Montes; Ashley M Goodwin; Michael P McDermott; David Uher; Feliz Marie Hernandez; Kayla Coutts; Julia Cocchi; Margarethe Hauschildt; Kayla M Cornett; Ashwini K Rao; Umrao R Monani; Carol Ewing Garber; Darryl C De Vivo
Journal:  Ann Clin Transl Neurol       Date:  2021-03-31       Impact factor: 5.430

4.  Spinal Muscular Atrophy Type 3 Showing a Specific Pattern of Selective Vulnerability on Muscle Ultrasound.

Authors:  Ryutaro Nakamura; Akihiro Kitamura; Takahito Tsukamoto; Yuhei Otowa; Naoki Okamoto; Nobuhiro Ogawa; Isamu Yamakawa; Hyoh Kim; Mitsuru Sanada; Makoto Urushitani
Journal:  Intern Med       Date:  2021-01-15       Impact factor: 1.271

5.  Caregiver burden and health-related quality of life in idiopathic dystonia patients under botulinum toxin treatment: a cross-sectional study.

Authors:  S C Drexel; M Klietz; F Wegner; D Dressler; K Kollewe; L Paracka; A Kutschenko; B Kopp; F Lange
Journal:  J Neural Transm (Vienna)       Date:  2019-12-04       Impact factor: 3.575

6.  Pilot Study on Quantitative Cervical Cord and Muscular MRI in Spinal Muscular Atrophy: Promising Biomarkers of Disease Evolution and Treatment?

Authors:  Giovanni Savini; Carlo Asteggiano; Matteo Paoletti; Stefano Parravicini; Elena Pezzotti; Francesca Solazzo; Shaun I Muzic; Francesco Santini; Xeni Deligianni; Alice Gardani; Giancarlo Germani; Lisa M Farina; Niels Bergsland; Claudia A M Gandini Wheeler-Kingshott; Angela Berardinelli; Stefano Bastianello; Anna Pichiecchio
Journal:  Front Neurol       Date:  2021-03-29       Impact factor: 4.003

7.  Muscle MRI as a Useful Biomarker in Hereditary Transthyretin Amyloidosis: A Pilot Study.

Authors:  Guido Primiano; Tommaso Verdolotti; Gabriella D'Apolito; Andrea Di Paolantonio; Valeria Guglielmino; Angela Romano; Gabriele Lucioli; Marco Luigetti; Serenella Servidei
Journal:  Genes (Basel)       Date:  2021-11-11       Impact factor: 4.096

8.  Neuroanatomical Models of Muscle Strength and Relationship to Ambulatory Function in Spinal Muscular Atrophy.

Authors:  Rafael Rodriguez-Torres; Julia Fabiano; Ashley Goodwin; Ashwini K Rao; Stacy Kinirons; Darryl De Vivo; Jacqueline Montes
Journal:  J Neuromuscul Dis       Date:  2020

9.  Muscle MRI in two SMA patients on nusinersen treatment: A two years follow-up.

Authors:  Andrea Barp; Elena Carraro; Emilio Albamonte; Francesca Salmin; Christian Lunetta; Giacomo Pietro Comi; Carmelo Messina; Domenico Albano; Vito Chianca; Luca Maria Sconfienza; Eugenio Maria Mercuri; Valeria Ada Sansone
Journal:  J Neurol Sci       Date:  2020-07-29       Impact factor: 3.181

10.  Serum creatine kinase and creatinine in adult spinal muscular atrophy under nusinersen treatment.

Authors:  Maren Freigang; Claudia D Wurster; Tim Hagenacker; Benjamin Stolte; Markus Weiler; Christoph Kamm; Olivia Schreiber-Katz; Alma Osmanovic; Susanne Petri; Alexander Kowski; Thomas Meyer; Jan C Koch; Isabell Cordts; Marcus Deschauer; Paul Lingor; Elisa Aust; Daniel Petzold; Albert C Ludolph; Björn Falkenburger; Andreas Hermann; René Günther
Journal:  Ann Clin Transl Neurol       Date:  2021-03-31       Impact factor: 4.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.